•  
  •  
  •  
  •  

2025-10-21 07:35:14

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Marathon Nextgen Realty announces one of the Largest Commercial Projects in Mumbai in JV with Adani Realty
  • Geojit Financial Services Ltd consolidated Q2FY26 PAT falls to Rs. 22.37 crores
  • VMS TMT bags more than 10,000 Metric Ton Order from Distributor Network amounting to approx. ₹ 46 Crores
  • AB Cotspin announces Order worth around ₹5.45 Crore for 200 MT of Cotton Yarn
  • Unimech Aerospace commissions two new manufacturing facilities at Bengaluru, KIADB Park

Keywords Selected:  Inspection

Stock Report

  • Innova Captab Limited updates on SMDC inspection
  • Biocon Limited updates on GMP inspection by USFDA at its Cranbury, New Jersey facility
  • Lupin gets one observation from USFDA for Somerset, New Jersey manufacturing facility
  • Emcure Pharmaceuticals Ltd completes surveillance inspection by USFDA without any observation
  • Zydus receives EIR for the oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Jubilant Pharmova announces Completion of Pharmacovigilance Inspection by the USFDA with No Observations
  • Lupin gets 4 observations from USFDA from PAI at Pune Biotech facility
  • USFDA successfully completes inspection at Indoco's API manufacturing facility at Patalganga with zero observations
  • Lupin receives 6 observations from USFDA for Nagpur Injectable facility
  • Tyche Industries Ltd completes GMP inspection by ANVISA
  • USFDA conducts product specific pre-approval inspection at Lupin Ltd's Aurangabad facility
  • Closure of USFDA inspection at Zydus' injectable manufacturing plant at Jarod
  • U.S. FDA Completes Inspection at Biocon Biologics' Facility at Biocon Campus, Bengaluru, India
  • Concord Biotech Limited completes EUGMP inspection at its API facility
  • Concord Biotech Ltd successfully completes Russian GMP insepction at its API facility
  • Concord Biotech Ltd announces successful completion EU GMP inspection at its API facility
  • EIR from USFDA, for Shilpa Medicare Ltd. Unit VI, Bengaluru.
  • Shilpa Pharma Lifesciences Limited, Unit-1, ANVISA Audit from Brazil
  • Granules India Ltd receives 1 observation from USFDA for Chantilly facility
  • SMS Pharmaceuticals Ltd successfully completes USFDA inspection at Central Laboratory Analytical Services
  • Gland Pharma Ltd receives EIR from US FDA for JNPC Facility, Visakhapatnam
  • Unichem Laboratories Ltd receives Form 483 from USFDA with 3 observations for Roha API facility
  • NATCO Pharma Ltd announces conclusion of USFDA inspection at Pharma Division, Kothur
  • U.S. FDA inspection at Glenmark Pharma's Facility at Monroe, North Carolina, USA

Latest Post

  • Marathon Nextgen Realty announces one of the Largest Commercial Projects in Mumbai in JV with Adani Realty
  • Geojit Financial Services Ltd consolidated Q2FY26 PAT falls to Rs. 22.37 crores
  • VMS TMT bags more than 10,000 Metric Ton Order from Distributor Network amounting to approx. ₹ 46 Crores
  • AB Cotspin announces Order worth around ₹5.45 Crore for 200 MT of Cotton Yarn
  • Unimech Aerospace commissions two new manufacturing facilities at Bengaluru, KIADB Park


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024